You are here: Home » News-CM » Companies » Results
Business Standard

Nectar Lifescience consolidated net profit declines 24.66% in the December 2019 quarter

Capital Market 

Sales decline 11.55% to Rs 647.96 crore

Net profit of Nectar Lifescience declined 24.66% to Rs 8.22 crore in the quarter ended December 2019 as against Rs 10.91 crore during the previous quarter ended December 2018. Sales declined 11.55% to Rs 647.96 crore in the quarter ended December 2019 as against Rs 732.60 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales647.96732.60 -12 OPM %8.648.91 -PBDT25.4930.79 -17 PBT10.2713.91 -26 NP8.2210.91 -25

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, February 11 2020. 16:17 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU